{"organizations": [], "uuid": "631ef77520526323ae6b65ee749f77347ea8f0e0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180530.html", "section_title": "Archive News &amp; Video for Wednesday, 30 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/products-testosterone/thai-drugmaker-besins-escapes-testosterone-replacement-litigation-idUSL2N1T201I", "country": "US", "domain_rank": 408, "title": "Thai drugmaker Besins escapes testosterone replacement litigation", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.948, "site_type": "news", "published": "2018-05-31T08:44:00.000+03:00", "replies_count": 0, "uuid": "631ef77520526323ae6b65ee749f77347ea8f0e0"}, "author": "Tina Bellon", "url": "https://www.reuters.com/article/products-testosterone/thai-drugmaker-besins-escapes-testosterone-replacement-litigation-idUSL2N1T201I", "ord_in_thread": 0, "title": "Thai drugmaker Besins escapes testosterone replacement litigation", "locations": [], "entities": {"persons": [{"name": "matthew kennelly", "sentiment": "none"}, {"name": "besins", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "chicago", "sentiment": "none"}], "organizations": [{"name": "abbvie inc", "sentiment": "none"}, {"name": "westlaw", "sentiment": "none"}, {"name": "thomson reuters trust principles", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "A federal judge overseeing the multidistrict litigation over testosterone replacement products that men allege cause cardio-vascular diseases has granted Thailand-based drugmaker Besins’ request to be tossed from the litigation.\nU.S. District Judge Matthew Kennelly in Chicago on Tuesday granted Besins’ summary judgment motion, finding that plaintiffs had failed to offer any evidence to support allegations against the company, which was sued along with its U.S. licensee AbbVie Inc.\nTo read the full story on Westlaw Practitioner Insights, click here: bit.ly/2J437lK\nOur Standards: The Thomson Reuters Trust Principles. 0 : 0 narrow-browser-and-phone medium-browser-and-portrait-tablet landscape-tablet medium-wide-browser wide-browser-and-larger medium-browser-and-landscape-tablet medium-wide-browser-and-larger above-phone portrait-tablet-and-above above-portrait-tablet landscape-tablet-and-above landscape-tablet-and-medium-wide-browser portrait-tablet-and-below landscape-tablet-and-below Apps Newsletters Advertise with Us Advertising Guidelines Cookies Terms of Use Privacy\nAll Quote: s delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.\n© 2018 Reuters. All Rights Reserved.", "external_links": ["http://bit.ly/2J437lK", "https://www.youtube.com/user/ReutersVideo", "https://twitter.com/reuters", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-31T08:44:00.000+03:00", "crawled": "2018-05-31T16:14:36.000+03:00", "highlightTitle": ""}